Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma
Background: Chemopreventive agent (CPA) treatment is one of the main preventive options for lung cancer. However, few studies have been done on pharmacodynamic biomarkers of known CPAs for lung cancer. Materials and methods: In this study, we treated mouse models of lung squamous cell carcinoma with...
Main Authors: | Yu Zhou, Qi Zhang, Meijun Du, Donghai Xiong, Yian Wang, Altaf Mohammed, Ronald A. Lubet, Liang Wang, Ming You |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/4/477 |
Similar Items
-
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
by: Ida Manna, et al.
Published: (2020-09-01) -
The role of Exosomal miRNAs in cancer
by: Chuanyun Li, et al.
Published: (2022-01-01) -
Connection of Cancer Exosomal LncRNAs, Sponging miRNAs, and Exosomal Processing and Their Potential Modulation by Natural Products
by: Ya-Ting Chuang, et al.
Published: (2023-04-01) -
Exosomal miRNAs in hepatocellular carcinoma development and clinical responses
by: Shuangshuang Li, et al.
Published: (2018-04-01) -
Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes
by: Leila Jahangiri, et al.
Published: (2022-05-01)